DISCOVER
Managed Access Programmes
Our technological innovation platform called “CleanWeb-MAP” (CleanWeb Managed Access Programme) facilitates access to new drugs by eligible patients.
There are multiple terms that fall under the umbrella of MAP, including Compassionate Use, Early Access, Named Patient Use and Individual Patient Request Programmes to name but a few. The terms used may vary from country to country depending on local laws and regulations. Our module is closely linked to our CleanWeb software platform for medical data collection, it enables self-registration of prescribing physicians and pharmacists, for each new product related to MAP.
Ethical and compliant
mechanism of access to drugs
• MAPs provide alternative treatments to patients with life-threatening diseases with no therapeutic options
• CleanWeb-MAP meets local laws and regulations Seamless Managed Access Programmes
Entrust your project
to our expert
data management team
Drug use outcome
in a real-world setting
Allows you to gain valuable early experience with a product
CleanWeb-MAP facilitates the management of MAPs in real-life conditions
CleanWeb-MAP:
streamlined interactions with stakeholders
Each role and access are clearly defined Physicians, Nurses, Medical Advisor, Programme Manager, Pharmacovigilance officer, Logistics perfectly interact in the MAP cycle process.
The ordering process and the availability of drugs are assured in interaction with any external system and data source.
CleanWeb-MAP allows for the involvement of other stakeholders and for the integration of many additional behaviours (e.g., Pharmacist).
Do you want to learn more about our e-health solution? Just fill in the form and we will get back to you shortly
A LEADING POSITION AND
AN INTERNATIONAL DEPLOYMENT
64 +
countries
involved
20 000 +
investigational
Centres
3 million +
patients
in database
50 000 +
users
worlwide
LATEST NEWSOUR NEWS >
April 30, 2024
May 14, 2024 – 1:15 PM to 2:00 PM (CEST) Join us for a comprehensive exploration of eTMF, where seasoned experts will discuss its significance, advantages, implementation challenges, regulatory compliance, and future trends. Our esteemed panel will share practical strategies and innovations to streamline eTMF utilisation in clinical trials. Our webinar will focus on an […]
April 30, 2024
Med City News Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions. Intellectual property can be a thorny issue in health tech and medtech. The intersection of healthcare data and AI is setting up […]
April 30, 2024
Med City News The nursing profession today is faced with a rising demand for care for an aging Baby Boomer population while simultaneously experiencing shortages related to a lack of educators, workforce geographic distribution, and high turnover. The American Association of Colleges of Nursing (AACN) reports that nursing schools are struggling to expand capacity to […]